A. Miyajima

1.1k total citations
27 papers, 992 citations indexed

About

A. Miyajima is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, A. Miyajima has authored 27 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in A. Miyajima's work include Bladder and Urothelial Cancer Treatments (6 papers), Immune Cell Function and Interaction (4 papers) and Urinary and Genital Oncology Studies (4 papers). A. Miyajima is often cited by papers focused on Bladder and Urothelial Cancer Treatments (6 papers), Immune Cell Function and Interaction (4 papers) and Urinary and Genital Oncology Studies (4 papers). A. Miyajima collaborates with scholars based in Japan, France and United States. A. Miyajima's co-authors include Tomoya Yokota, Taisei Kinoshita, Toshio Kitamura, Katsumitsu Arai, D M Gorman, Misa Onishi, Garry P. Nolan, Lewis L. Lanier, Joseph H. Phillips and Yoshihiro Morikawa and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Lab on a Chip.

In The Last Decade

A. Miyajima

27 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Miyajima Japan 14 452 348 223 193 100 27 992
Erica N Evans United States 19 379 0.8× 487 1.4× 187 0.8× 68 0.4× 80 0.8× 44 1.2k
Yigang Chang Canada 15 394 0.9× 235 0.7× 190 0.9× 184 1.0× 53 0.5× 22 859
Lorena Maestre Spain 15 744 1.6× 325 0.9× 442 2.0× 109 0.6× 32 0.3× 23 1.4k
B E Elliott Canada 17 382 0.8× 571 1.6× 351 1.6× 101 0.5× 133 1.3× 29 1.2k
James I. Kim United States 17 797 1.8× 531 1.5× 159 0.7× 223 1.2× 42 0.4× 28 1.5k
E Gorelik United States 17 419 0.9× 306 0.9× 238 1.1× 71 0.4× 55 0.6× 27 800
Kevin B. Leslie Canada 12 335 0.7× 494 1.4× 236 1.1× 57 0.3× 108 1.1× 16 919
Seong Hoe Park South Korea 16 329 0.7× 393 1.1× 351 1.6× 40 0.2× 41 0.4× 24 906
Kevin T. Merrell United States 14 761 1.7× 588 1.7× 170 0.8× 65 0.3× 147 1.5× 17 1.4k
Deborah Hardie United Kingdom 10 715 1.6× 382 1.1× 206 0.9× 45 0.2× 123 1.2× 15 1.2k

Countries citing papers authored by A. Miyajima

Since Specialization
Citations

This map shows the geographic impact of A. Miyajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Miyajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Miyajima more than expected).

Fields of papers citing papers by A. Miyajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Miyajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Miyajima. The network helps show where A. Miyajima may publish in the future.

Co-authorship network of co-authors of A. Miyajima

This figure shows the co-authorship network connecting the top 25 collaborators of A. Miyajima. A scholar is included among the top collaborators of A. Miyajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Miyajima. A. Miyajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hayakawa, Nozomi, Shinya Morita, Kazunobu Shinoda, et al.. (2015). 10 Bladder metastasis from renal cell carcinoma: Retrospective analysis of 65 reported cases. European Urology Supplements. 14(2). e10–e10b. 1 indexed citations
3.
Mikami, Shuji, et al.. (2012). Prognostic Significance of High Nuclear Grade in Patients with Pathologic T1a Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 42(9). 831–835. 16 indexed citations
4.
Hoshino, Ken, Eiji Kikuchi, Nobuyuki Tanaka, et al.. (2012). Preoperative Hydronephrosis: Independent Predictor for Changes in Renal Function Following Nephroureterectomy. Japanese Journal of Clinical Oncology. 42(3). 202–207. 20 indexed citations
5.
Miyajima, A., et al.. (2012). The Benefit of Laparoscopic Partial Nephrectomy in High Body Mass Index Patients. Japanese Journal of Clinical Oncology. 42(7). 619–624. 10 indexed citations
6.
Kikuchi, Eiji, et al.. (2011). Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer. Japanese Journal of Clinical Oncology. 41(7). 908–914. 27 indexed citations
7.
Yuge, Kazuyuki, et al.. (2011). Could Patient Age Influence Tumor Recurrence Rate in Non-muscle-invasive Bladder Cancer Patients Treated with BCG Immunotherapy?. Japanese Journal of Clinical Oncology. 41(4). 565–570. 19 indexed citations
8.
Miyajima, A., et al.. (2010). Benefit of Laparoscopic Radical Nephrectomy in Patients with a High BMI. Japanese Journal of Clinical Oncology. 41(3). 400–404. 11 indexed citations
9.
Miyajima, A., et al.. (2009). Extraperitoneal Approach Induces Postoperative Inguinal Hernia Compared with Transperitoneal Approach after Laparoscopic Radical Prostatectomy. Japanese Journal of Clinical Oncology. 40(4). 349–352. 26 indexed citations
10.
Ide, Hiroki, Eiji Kikuchi, Hirohiko Nagata, et al.. (2009). Docetaxel in Combination with Prednisolone for Hormone Refractory Prostate Cancer. Japanese Journal of Clinical Oncology. 40(1). 79–84. 14 indexed citations
11.
Miyajima, A., et al.. (2009). 892 ANGIOTENSIN II TYPE I ANTAGONIST PREVENTS HORMONE-REFRACTORY PROSTATE CANCER BY INHIBITING TUMOR ANGIOGENESIS. European Urology Supplements. 8(4). 343–343. 1 indexed citations
12.
Baba, Shiro, A. Miyajima, Yoshiaki Uchida, et al.. (1997). A posterior lumbar approach for retroperitoneoscopic adrenalectomy: Assessment of surgical efficacy. Urology. 50(1). 19–24. 73 indexed citations
13.
Muto, Akihiko, Sumiko Watanabe, A. Miyajima, Takashi Yokota, & Ken‐ichi Arai. (1995). High-Affinity Chimeric Human Granulocyte-Macrophage Colony-Stimulating Factor-Receptor Carrying the Cytoplasmic Domain of the β Subunit But Not the α Subunit Transduces Growth-Promoting Signals in Ba/F3 Cells. Biochemical and Biophysical Research Communications. 208(1). 368–375. 31 indexed citations
14.
Ohigashi, Takashi, A. Miyajima, Yoshiaki Uchida, Seido Jitsukawa, & Munehisa Ueno. (1995). USE OF SEMIRIGID URETEROSCOPES FOR TREATMENT OF URETERAL CALCULI. The Japanese Journal of Urology. 86(11). 1636–1642. 1 indexed citations
15.
Nishikomori, Ryuta, Minoru Kawai, Guixiang Tai, et al.. (1995). Cis -acting DNA elements of mouse granulocyte-macrophage colony-stimulating factor gene responsive to Fc epsilon receptor cross-linking stimulation in the mouse mast cell line MC/9.. The Journal of Immunology. 154(2). 694–702. 3 indexed citations
16.
Kinoshita, Taisei, Tomoya Yokota, Katsumitsu Arai, & A. Miyajima. (1995). Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells.. PubMed. 10(11). 2207–12. 133 indexed citations
17.
Yokota, Takashi, S. WATANABE, Alice Mui, et al.. (1993). Reconstitution of functional human GM-CSF receptor in mouse NIH3T3 fibroblasts and BA/F3 proB cells.. PubMed. 7 Suppl 2. S102–7. 1 indexed citations
18.
Schreurs, Jolanda, et al.. (1991). AIC2A is a component of the purified high affinity mouse IL-3 receptor: temperature-dependent modulation of AIC2A structure. International Immunology. 3(12). 1231–1242. 17 indexed citations
19.
Arai, Ken‐ichi, Junko Nishida, Kazuhiro Hayashida, et al.. (1990). [Coordinate regulation of immune and inflammatory responses by cytokines].. PubMed. 38(4). 347–53. 8 indexed citations
20.
Malefyt, René de Waal, Balbino Alarcón, Hans Yssel, et al.. (1989). Introduction of T cell receptor (TCR)-alpha cDNA has differential effects on TCR-gamma delta/CD3 expression by PEER and Lyon-1 cells.. The Journal of Immunology. 142(10). 3634–3642. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026